SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000898430-03-001854
Filing Date
2003-03-10
Accepted
2003-03-10 17:08:48
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1885851
3 AGREEMENT BETWEEN AMGEN INC. AND EDWARD FRITZKY dex1082.htm EX-10.82 105341
4 AMENDMENT NO. 3 TO ENBREL SUPPLY AGREEMENT dex1087.htm EX-10.87 33585
5 AMGEN LIMITED 2000 UK CO. EMPLOYEE SHARE OPTION PLAN dex1089.htm EX-10.89 75550
6 RESTRICTED STOCK PURCHASE AGREEMENT dex1090.htm EX-10.90 27170
7 SUBSIDIARIES OF THE COMPANY dex21.htm EX-21 2375
9 GRAPHIC g75013g24e57.jpg GRAPHIC 16854
  Complete submission text file 0000898430-03-001854.txt   2149142
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12477 | Film No.: 03598424
SIC: 2836 Biological Products, (No Diagnostic Substances)